AI Circle Daily
https://aicircle.news/archive/2026-07-12?category=finance&lang=en
Scan to read this page
Iran shuts the Strait of Hormuz after an 'unauthorized vessel' incident, with the IRGC navy declaring closure until further notice.
Take: This chokes ~20% of global oil transit. Expect an immediate spike in crude, risk-off across equities, and a flight to gold and USD.
Trump says 1,000 missiles are 'locked and loaded' against Iran if it attempts to assassinate him; Treasury sanctions an alleged Iranian financier.
Take: Escalation from rhetoric to explicit military threat, on top of the Strait closure. Markets will price in conflict risk—volatility surges.
Deutsche Bank outlines three key points supporting the dollar's long-term trajectory, signaling structural strength.
Take: Safe-haven flows and rate differentials keep USD bid. DB's call reinforces the consensus that a sustained dollar decline is unlikely.
The Dow Jones hovers near all-time highs but faces earnings season, CPI, and US-Iran tensions, raising volatility expectations.
Take: Geopolitical, inflation, and earnings risks converge. At these levels, downside skew is building—prudent to trim risk.
Russian air strikes kill eight and wound dozens in Ukraine; Zelenskiy urges faster Western weapons deliveries.
Take: War fatigue has made this a secondary factor, but accelerated arms flows could reignite geopolitical risk premium in energy and safe havens.
Berkshire Hathaway's B shares are down 1.8% YTD, trailing the S&P 500's 10.7% gain by 12.4 percentage points.
Take: Value and cash-heavy positioning is getting crushed in an AI-led rally. Mean reversion bets are painful—timing is everything.
SK Hynix jumps 13% on its first Nasdaq trading day; chairman says demand is 'enormous.' Market cap exceeds $1 trillion.
Take: AI memory demand remains red-hot. SK Hynix is the HBM leader, but post-IPO valuation is stretched—chasing here is risky.
Apple files a lawsuit alleging OpenAI stole trade secrets 'at every level,' relating to their 2024 ChatGPT-iPhone integration deal.
Take: Legal risks in AI are crystallizing. This breakup could reshape AI partnerships—negative for names overly reliant on single ecosystems.
New US housing legislation aims to improve affordability, but experts say benefits will take time to materialize.
Take: Housing supply/demand imbalance won't be fixed overnight. Near-term impact on REITs and homebuilders is muted; long-term could cool price growth.
AstraZeneca's clinical trial failure questions its pipeline premium, as it has commanded one of the richest valuations among large European pharma firms.
Take: Pipeline-dependent valuations are fragile. This could spill over to other high-multiple pharma names—re-rating risk is real.